JLBC
JNJ icon

J.L. Bainbridge & Co’s Johnson & Johnson JNJ Stock Holding History

J.L. Bainbridge & Co’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$821K Buy
3,234
+1
+0% +$233 0.06% 48
2026
Q1 		$790K Sell
3,233
-3,518
-52% -$819K 0.07% 45
2025
Q4 		$1.4M Sell
6,751
-687
-9% -$136K 0.11% 38
2025
Q3 		$1.38M Sell
7,438
-1,134
-13% -$194K 0.12% 38
2025
Q2 		$1.31M Sell
8,572
-126,565
-94% -$19.5M 0.12% 38
2025
Q1 		$22.4M Sell
135,137
-2,104
-2% -$329K 2.25% 19
2024
Q4 		$19.8M Buy
137,241
+2,686
+2% +$416K 1.84% 19
2024
Q3 		$21.8M Sell
134,555
-453
-0.3% -$72.2K 2.09% 20
2024
Q2 		$19.7M Buy
135,008
+9,933
+8% +$1.48M 1.96% 22
2024
Q1 		$19.8M Sell
125,075
-32,550
-21% -$5.18M 2.11% 20
2023
Q4 		$24.7M Sell
157,625
-7,199
-4% -$1.1M 3.02% 15
2023
Q3 		$25.7M Buy
164,824
+4,019
+2% +$663K 3.44% 10
2023
Q2 		$26.6M Sell
160,805
-1,111
-0.7% -$179K 3.32% 13
2023
Q1 		$25.1M Sell
161,916
-3,462
-2% -$559K 3.45% 13
2022
Q4 		$29.2M Sell
165,378
-2,841
-2% -$491K 4.53% 5
2022
Q3 		$27.5M Sell
168,219
-3,663
-2% -$620K 4.21% 7
2022
Q2 		$30.5M Buy
171,882
+3,114
+2% +$555K 4.54% 6
2022
Q1 		$29.9M Sell
168,768
-130
-0.1% -$22.1K 3.41% 11
2021
Q4 		$28.9M Buy
168,898
+832
+0.5% +$136K 3.21% 11
2021
Q3 		$27.1M Sell
168,066
-1,952
-1% -$333K 3.24% 12
2021
Q2 		$28M Buy
170,018
+2,816
+2% +$466K 3.35% 13
2021
Q1 		$27.5M Buy
167,202
+376
+0.2% +$60.8K 3.63% 10
2020
Q4 		$26.3M Sell
166,826
-1,616
-1% -$238K 3.7% 11
2020
Q3 		$25.1M Sell
168,442
-3,135
-2% -$464K 3.97% 9
2020
Q2 		$24.1M Buy
171,577
+115,820
+208% +$16.9M 4.39% 8
2020
Q1 		$7.31M Buy
55,757
+49,640
+812% +$7.04M 1.39% 18
2019
Q4 		$892K Buy
6,117
+16
+0.3% +$2.17K 0.12% 31
2019
Q3 		$789K Buy
6,101
+13
+0.2% +$1.71K 0.12% 29
2019
Q2 		$848K Buy
6,088
+256
+4% +$35.4K 0.13% 29
2019
Q1 		$829K Sell
5,832
-4,765
-45% -$638K 0.12% 28
2018
Q4 		$497K Buy
10,597
+3,880
+58% +$541K 0.09% 35
2018
Q3 		$928K Buy
+6,717
New +$893K 0.13% 24

Other funds holding JNJ

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

J.L. Bainbridge & Co's JNJ Position: Q2 2026 in Review

J.L. Bainbridge & Co increased its Johnson & Johnson (JNJ) stake by 0.03% in Q2 2026, buying an estimated $233 and bringing the position to 3,234 shares worth $821K. The position accounts for 0.06% of the portfolio, ranked #48.

J.L. Bainbridge & Co first reported a position in JNJ in Q3 2018 and has held it in 32 quarters since. The position peaked at $30.5M in Q2 2022. 2,719 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • J.L. Bainbridge & Co held 3,234 shares of Johnson & Johnson worth $821K as of Q2 2026.
  • J.L. Bainbridge & Co bought 1 Johnson & Johnson share in Q2 2026, an estimated $233.
  • Johnson & Johnson made up 0.06% of J.L. Bainbridge & Co's portfolio in Q2 2026, its #48 holding.
  • J.L. Bainbridge & Co first reported a position in Johnson & Johnson in Q3 2018 and has held it in 32 quarters since.
  • J.L. Bainbridge & Co's Johnson & Johnson position peaked at $30.5M in Q2 2022.
  • 2,719 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on J.L. Bainbridge & Co's 13F filing for Q2 2026, filed 22 Jul 2026.